Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis

Overview of attention for article published in The Journal of Headache and Pain, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,357 followers.

RT @NeuroPsychBMC: Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a sy…

07 Jun 2020

Reply Repost Favourite

Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis https://t.co/06WdmvW00X

06 Jun 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.